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Abstract
Background: Gap junctions facilitate exchange of small molecules between adjacent cells, serving a crucial
function for the maintenance of cellular homeostasis. Mutations in connexins, the basic unit of gap junctions,
are associated with several human hereditary disorders. For example, mutations in connexin26 (Cx26) cause
both non-syndromic deafness and syndromic deafness associated with skin abnormalities such as keratitis-
ichthyosis-deafness (KID) syndrome. These mutations can alter the formation and function of gap junction channels
through different mechanisms, and in turn interfere with various cellular processes leading to distinct disorders. The
KID associated Cx26 mutations were mostly shown to result in elevated hemichannel activities. However, the effects of
these aberrant hemichannels on cellular processes are recently being deciphered. Here, we assessed the effect of two
Cx26 mutations associated with KID syndrome, Cx26I30N and D50Y, on protein biosynthesis and channel function in
N2A and HeLa cells.
Results: Immunostaining experiments showed that Cx26I30N and D50Y failed to form gap junction plaques at cell-cell
contact sites. Further, these mutations resulted in the retention of Cx26 protein in the Golgi apparatus. Examination
of hemichannel function by fluorescent dye uptake assays revealed that cells with Cx26I30N and D50Y mutations had
increased dye uptake compared to Cx26WT (wild-type) containing cells, indicating abnormal hemichannel activities.
Cells with mutant proteins had elevated intracellular calcium levels compared to Cx26WT transfected cells, which were
abolished by a hemichannel blocker, carbenoxolone (CBX), as measured by Fluo-3 AM loading and flow cytometry.
Conclusions: Here, we demonstrated that Cx26I30N and D50Y mutations resulted in the formation of aberrant
hemichannels that might result in elevated intracellular calcium levels, a process which may contribute to the
hyperproliferative epidermal phenotypes of KID syndrome.
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Background
Gap junctions facilitate the intercellular communication
between adjacent cells by allowing the exchange of small
molecules that play roles in the regulation of many cellular
events including proliferation, differentiation and cellular
homeostasis [1, 2]. Gap junction biosynthesis starts in the
ER-Golgi network by the oligomerization of six connexin
subunits into hemichannels, known as connexons. Then,
these connexons are transported to the plasma membrane
where they can either align with other connexons from
neighboring cells to complete the formation of intercellu-
lar channels, or function individually on the plasma mem-
brane as hemichannels that can mediate the exchange of
materials between the cell interior and the extracellular
environment [3–8].
Gap junction channels and hemichannels are import-
ant modulators of tissue homeostasis as evidenced by
the association of mutations in connexin genes with
several hereditary disorders. For example, mutations in
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family, are the leading cause of non-syndromic hearing
loss (NSHL) [9]. To date, more than 100 NSHL muta-
tions throughout the Cx26 gene (GJB2) have been iden-
tified, and functional characterization of these mutations
suggested that the majority are loss-of-function muta-
tions that can lead to protein truncation, altered traffick-
ing, misfolding of Cx26 protein or altered channel
permeability [3, 10–12]. In addition to NSHL, Cx26
mutations were linked to syndromic deafness associated
with various skin pathologies including keratitis-
ichthyosis-deafness (KID) syndrome, palmoplantar kera-
toderma (PPK) and Vohwinkel syndrome (VS) [13].
Generation of diverse epidermal phenotypes during
aforementioned skin disorders driven by different Cx26
mutations imply that associated mutations may have
unique properties affecting distinct cellular machinery
[3, 10, 14].
KID syndrome is a rare congenital genetic disorder
with phenotypes of thickening of the skin, keratisis, scaly
skin (ichthyosis) and deafness [15, 16]. The Cx26A40V
was the first KID syndrome associated mutation that
was shown to cause increased hemichannel activities and
cell death in mRNA injected Xenopus oocytes [17]. Other
studies on different KID syndrome mutations also sug-
gested the involvement of altered hemichannel activities
and cell death in both Xenopus oocytes and mamma-
lian cell lines as a common mechanism for this dis-
order [18–22]. However, the molecular mechanisms
that lead to cell death, and skin phenotypes due to
active hemichannels are poorly understood. For that,
we characterized two more KID syndrome mutations,
Cx26I30N and D50Y, in order to understand whether
they affect the protein biosynthetic pathway, hemi-
channel activities similar to previously characterized
KID syndrome mutations and intracellular calcium
levels that play essential roles in cellular processes,Fig. 1 Effect of Cx26I30N and D50Y mutations on protein expression and l
HeLa cells that were co-stained with phalloidin for actin (green) and Cx26 a
head shows the gap junction plaques formed between adjacent Cx26W
sites between neighboring cells of Cx26I30N and D50Y. Cells with only gespecially in keratinocyte proliferation, differentiation
and migration [23–25].
Results
Protein localization of Cx26I30N and D50Y mutant
proteins
To examine the effects of Cx26I30N and D50Y KID syn-
drome associated mutations on protein synthesis and
localization, gap junctional communication deficient cell
line, HeLa, were transiently transfected with pIRE-
S2EGFP2 Cx26WT (wild-type), I30N and D50Y con-
structs. 24 h after transfection, the protein synthesis and
localization was determined by immunofluorescent
staining of transfected cells (Fig. 1). Immunofluorescent
staining with Cx26 specific antibody demonstrated that
cells expressing Cx26WT, I30N and D50Y constructs
were able to synthesize Cx26 proteins (Fig. 1). Further,
cells transfected with Cx26WT targeted proteins to the
plasma membrane where they formed gap junction pla-
ques at the cell-to-cell junctions between adjacent cells
(Fig. 1, white arrow head). On the other hand, in spite of
positive protein synthesis in cells with Cx26I30N or
D50Y constructs, no gap junctional plaques were ob-
served between neighboring cells expressing mutant
constructs (Fig. 1, red arrow heads). This suggested that
Cx26I30N and D50Y proteins failed to form gap junc-
tion plaques between adjacent cells.
Effect of Cx26I30N and D50Y mutations on the Cx26
protein trafficking
In order to determine the location of Cx26 proteins
within cells, co-labelling of Cx26 protein with golgin-97,
a Golgi apparatus marker, or Cx26 protein with Wheat
germ agglutinin (WGA), for the plasma membrane
staining, were performed (Fig. 2). As observed in images
in Fig. 2a, there was no overlap between Cx26 and
golgin-97 protein signals in Cx26WT expressing cellsocalization. Merged images of Cx26WT, I30N and D50Y transfected
ntibody (red). Blue is for DAPI staining of the nucleus. White arrow
T expressing cells. Red arrow heads point the cell-to-cell contact
reen and blue signals indicate untransfected cells. Scale bar 10 μm
Cx26WT Cx26I30N Cx26D50Y
Cx26WT Cx26I30N Cx26D50Y
a
b
Fig. 2 Effect of Cx26I30N and D50Y mutations on protein trafficking. a Merged images of Cx26WT, I30N and D50Y transfected cells that were co-
stained with Cx26 (red) and the Golgi apparatus marker, golgin-97 (green) antibodies. Blue is for DAPI staining of the nucleus. Arrow heads point
the location of the Golgi apparatus. Yellow signals in Cx26I30N and D50Y images show the colocalization of Cx26 and golgin-97. Scale bar 10 μm.
b Merged images of Cx26WT, I30N and D50Y transfected cells that were co-stained with Cx26 (green) antibody and Rhodamine labeled wheat
germ agglutinin (WGA). Blue is for DAPI staining of the nucleus. Yellow signals shown by arrow heads point out the colocalization of Cx26 and
WGA. Scale bar 10 μm
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co-localized with golgin-97 in transfected cells as evi-
denced by the presence of yellow signals (Fig. 2a, red
arrow heads). Analysis of Costes’ colocalization values
through image processing revealed that 2 out of 25 (8 %)
images for Cx26WT had significant colocalization for
Cx26 protein and golgin-97 (p > 95 %). On the other
hand, 19 out of 33 images (58 %) for Cx26I30N and 13
out of 26 (50 %) for Cx26D50Y had significant co-
localization, ratios that were both significantly (p < 0.01)
higher compared to WT images (Table 1). Furthermore,
the membrane localization of Cx26WT, I30N and D50Y,Table 1 Analysis of colocalization between Cx26 and golgin-97,
the Golgi apparatus marker
Cells analyzed (n) Colocalization (n) Ratio (%)
Cx26WT 25 2 8a
Cx26I30N 33 19 58b
Cx26D50Y 26 13 50b
a,bDifferent letters indicate statistically significant differences among groupsthat was verified by Cx26 and Rhodamine labeled WGA
co-staining suggested that a fraction of proteins in all
conditions were localized to the plasma membrane
(Fig. 2b, arrow heads). These suggested that mutant pro-
teins can be found both in the Golgi apparatus and the
plasma membrane.
Altered hemichannel activities of Cx26I30N and D50Y
channels
Cx26 mutations associated with KID syndrome have
been shown to cause elevated hemichannel activities
[19, 21, 22]. Here, we determined the ability of
Cx26I30N mutation to form aberrant hemichannels in
addition to D50Y mutation that was previously shown
to result in elevated membrane currents in Xenopus
oocytes by electrophysiological measurements [26] in
mammalian cell lines with fluorescent dye uptake
assay using Neurobiotin (NB) (Fig. 3). Under physio-
logical calcium concentrations, Cx26WT hemichan-
nels had 10 % increase in the mean fluorescent
intensity of NB in cells compared to negative control.
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Fig. 3 Fluorescent dye uptake in Cx26WT, I30N and D50Y transfected cells. a Comparison of fluorescent dye intensities in transfected cells under
physiological calcium concentration. Cx26I30N and D50Y were compared with both negative control pIRES2EGFP2 and Cx26WT (*, p< 0.01). b Comparison
of fluorescent dye intensities in transfected cells in divalent free medium and in the presence of 100 μM CBX, a hemichannel blocker. Cx26WT, I30N and
D50Y were compared with negative control pIRES2EGFP2 (*, p< 0.01); Cx26I30N and D50Y were compared with Cx26WT (†, p< 0.01) and comparison
between samples treated with or without CBX was performed (‡, p< 0.01)
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cells had 1.5 fold increase in NB uptake with respect
to WT containing cells (n = 15 images, p < 0.01)
(Fig. 3a), suggesting an aberrant hemichannel activ-
ities. To further verify the formation of abnormal
hemichannels on the plasma membrane, dye uptake
studies were performed under divalent free conditions
and in the presence of a hemichannel blocker, carbe-
noxolone (CBX) (Fig. 3b). Analysis of NB fluorescent in-
tensity in EGFP positive cells suggested that the
fluorescent intensity of Cx26WT cells was 1.3 fold (n = 50
images, p < 0.01) higher than control cells and for I30N
and D50Y cells the fluorescent intensities increased by
1.3 (n = 60 images, p < 0.01) and 1.6 fold (n = 49 im-
ages, p < 0.01) compared to Cx26WT cells, respect-
ively (Fig. 3b). To determine if the uptake of NB intothe cells were mediated by Cx26I30N and D50Y ab-
normal hemichannels, cells were initially treated with
a hemichannel blocker, carbenoxolone (CBX) before
NB application. Treatment of cells with 100 μM CBX
for 20 min resulted in a 17 % and 35 % (both, p <
0.01) reduction in the levels of mean fluorescent in-
tensities in Cx26I30N and D50Y expressing cells com-
pared to their CBX absent counterparts, respectively.
These suggested that the increase in the uptake of
NB into cells were mediated by aberrant hemichan-
nels formed from Cx26I30N and D50Y.
Effect of Cx26I30N and D50Y mutations on intracellular
calcium signals
Calcium signals are essential for the maintenance of epi-
dermal homeostasis [27–29]. Therefore, we next wanted
Aypek et al. BMC Cell Biology  (2016) 17:5 Page 5 of 8to investigate whether Cx26I30N and D50Y mutations
have any effect on internal calcium content by using a
calcium indicator, Fluo-3 AM, and flow cytometry
(Fig. 4). Comparison of Fluo-3 AM signals in pCS2+,
Cx26WT, I30N and D50Y transfected cells demonstrated
that intracellular calcium content in both I30N and
D50Y transfected cells were elevated by 1.4 (p < 0.01)
and 1.6 fold (p < 0.01) compared to cells with pCS2+ and
Cx26WT clones, respectively (Fig. 4). This increase in
intracellular calcium content was reduced by 34 % and
50 % (both, p < 0.01) with the treatment of 100 μM CBX
in Cx26I30N and D50Y containing cells, respectively,
suggesting the involvement of aberrant hemichannels in
the elevation of intracellular calcium concentration
(Fig. 4).
Discussion
Characterization of Cx26 mutations associated with
KID syndrome will improve the understanding of
both Cx26 function in normal epidermal homeostasis
and generation of disease phenotypes in affected indi-
viduals. Examination of several Cx26 mutations sug-
gested that KID syndrome mutations lead to the
formation of active hemichannels on the plasma
membrane that might result in uncontrolled exchange
of molecules between the cytosol and the extracellular
environment, influencing the cellular/tissue homeosta-
sis [19, 30, 31]. Here, we characterized two additional
KID syndrome mutations, Cx26I30N and D50Y, in
order to understand their effect on the protein bio-
synthetic pathway, hemichannel activity and0
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Fig. 4 Effect of Cx26 mutations on intracellular calcium levels.
Intracellular calcium concentration determined by a calcium
indicator (Fluo-3 AM) using flow cytometry was compared
among pCS2+, Cx26WT, I30N and D50Y containing cells (*, p <
0.01). Comparison between 100 μM CBX treated and non-treated
samples was also performed (‡, p < 0.01)intracellular calcium levels in communication defi-
cient cell lines. We demonstrated that both mutants
failed to form gap junction plaques at cell-to-cell con-
tact sites between neighboring cells in contrast to
Cx26WT proteins even though a fraction of mutant
proteins was targeted to the plasma membrane.
Moreover, cells with mutant constructs had increased
uptake of neurobiotin fluorescent dye and elevated
intracellular calcium levels compared to cells with
Cx26WT which were abolished by carbenoxolone, a
hemichannel blocker. These observations provided
support for the contribution of aberrant hemichannels
and the involvement of altered calcium signals in KID
syndrome [18, 32].
Mutations in the Cx26 gene cause both non-syndromic
and syndromic deafness with skin pathologies. Each muta-
tion is unique in terms of defects they cause, that is, muta-
tions leading to various skin disorders result in distinct
molecular abnormalities within cells at different levels
from protein synthesis to the formation and the function
of gap junction channels [3, 12]. Mutations associated
with KID syndrome, for example, were shown to mostly
cause abnormal hemichannel activity leading to altered
regulation of molecular exchange through the plasma
membrane [19–22, 33]. Similar to many characterized
KID syndrome mutations, Cx26I30N and D50Y also re-
sulted in increased fluorescent dye uptake from the exter-
nal environment, suggesting the involvement of aberrant
hemichannel activities for these mutations.
Disease associated Cx26 mutations lead to different
molecular abnormalities that can interfere with the
cellular homeostasis [3]. Included among these are al-
teration in trafficking of proteins to the plasma mem-
brane, where they could prevent the formation of gap
junction plaques at cell-to-cell contact sites. Abnor-
mal membrane trafficking might result in the accu-
mulation of mutant proteins within the subcellular
structures including the ER, the ER-Golgi intermedi-
ate compartment or the Golgi apparatus [34–37]. In
this study, Cx26I30N and D50Y mutations were ob-
served to abolish the formation of gap junction pla-
ques between adjacent cells. Although mutant
proteins were observed on the plasma membrane,
they were also widely accumulated in the Golgi
apparatus. How mutations in isoleucine 30 (I30) and
aspartic acid at position 50 (D50) affect the
localization and function of Cx26 is not known. I30 is
found in the first transmembrane domain (TM1) that
was shown to be important for oligomerization and
channel function [1, 38]. The mutation of a nonpolar
residue into a polar amino acid (asparagine) might
affect the structure of the TM1 as asparagine can
form hydrogen bonds with other residues that can
affect the organization and stability of this domain.
Aypek et al. BMC Cell Biology  (2016) 17:5 Page 6 of 8The inability of I30N mutation to form gap junction
channels suggest that this amino acid might influence
the docking of hemichannels in the extracellular
space during the formation of gap junction channels.
The first extracellular loop (EC1) was shown to be in-
volved in connexon formation, docking of connexons
at the extracellular space and gap junction channel
function [1, 39]. D50 in EC1 is highly conserved
across species and across the connexin family [16].
The mutation of this charged amino acid might alter
the organization of the EC1, affecting the interactions
of connexons in the ESC as they are forming the gap
junction channels [22, 30].
The maintenance of calcium homeostasis is crucial
for proper functioning of keratinocytes and the
epidermis. Calcium plays roles in the regulation of
keratinocyte proliferation, differentiation and cellular
adhesion processes [29, 40]. Furthermore, there is a
calcium gradient across the epidermis with the lowest
concentration in the stratum basale and the highest
in the stratum granulosum. Maintenance of this
gradient and intracellular calcium levels are indispens-
able for epidermal cells as abnormalities in these pro-
cesses have been linked to a variety of skin disorders
[41–43]. Here, Cx26I30N and D50Y mutations were
shown to result in the elevation of intracellular cal-
cium in transfected cells compared to Cx26WT cells.
An increase in the intracellular calcium levels was also
observed for other Cx26 KID syndrome associated muta-
tions [18, 32]. Terrinoni et al. demonstrated that cells
with Cx26G11E and D50N mutations have an increased
amount of intracellular calcium 24 h post transfection
[18]. Moreover, Garcia et al. observed a significant in-
crease in the intracellular calcium levels in cells co-
expressing Cx43 and KID syndrome associated Cx26
mutant constructs compared to Cx43 alone cells [32].
Thus, deregulation of intracellular calcium mechanisms
by aberrant hemichannel activities may perturb several
calcium dependent cellular processes to contribute to the
development of skin phenotypes.
Conclusion
Formation of aberrant hemichannels due to Cx26I30N
and D50Y mutations provided further support for the in-
volvement of abnormal hemichannel activities as a com-
mon mechanism for KID syndrome. Uncontrolled
transport of signaling molecules such as ATP or calcium
through these channels may alter keratinocyte growth,
proliferation and/or differentiation that could play
role in the generation of dermatological anomalies in
KID patients. However, the molecular mechanisms al-
tered by aberrant Cx26 hemichannels affecting kera-
tinocyte proliferation, differentiation and migration
remain to be elusive.Methods
Site-directed mutagenesis and construction of Cx26
mutant clones
Cx26I30N and D50Y missense point mutations were
generated from human wild-type Cx26 cDNA in pBlue-
Script II (courtesy of Prof. Dr. Thomas W. White, Stony
Brook University, Stony Brook, NY, USA) by using site-
directed mutagenesis. PCR products were cloned into
pBlueScript II cloning vector and location and insertion of
mutations were verified by sequencing (Macrogen Europe,
the Netherlands). Then, Cx26WT, I30N and D50Y cDNAs
were subcloned into pIRES2EGFP2 (Clontech Laboratories,
USA) and pCS2+ mammalian expression vectors for im-
munostaining and functional studies.
Cell culture
Gap junctional communication deficient cell lines, HeLa
(human cervical cell line) and neuro-2A (N2A, mouse
neuroblastoma cell line) (purchased from ATCC, USA),
were maintained in Dulbecco’s Modified Eagle Medium
(DMEM, Thermo Scientific HyClone, USA) supplemented
with 10 % fetal bovine serum (FBS) (Biological Industries,
Israel) and 1 % penicillin/streptomycin (GIBCO, USA) in
a humidified chamber with 5 % CO2 and 37 °C. For exper-
iments, cells were plated in 6 well plates so that they
would reach 70-80 % confluence on the day of transfec-
tion with Lipofectamine 2000 reagent (Invitrogen, USA).
Cells were transfected with 1:2 DNA to Lipofectamine
2000 ratio following the manufacturer’s protocol and
3.2 mM CaCI2 was added to prevent the cell death due to
the activities of prospective hemichannels. Cells were used
within 24–48 h after transfection.
Immunofluorescent stainings
HeLa cells (2,5x105) were grown over glass coverslips in 6
well plates for immunofluorescent staining experiments.
24 h post transfection, cells were washed with PBS and
then fixed with 4 % paraformaldehyde (PFA) for 20 min,
permeabilized with 0.1 % Triton-X 100 for 15 min and
blocked with 3 % bovine serum albumin (BSA) for 1 h at
room temperature (RT). Cells were then incubated with a
1:500 dilution of a polyclonal rabbit antibody against Cx26
(Invitrogen, USA) for 1 h at RT followed by an application
of a 1:200 dilution of Alexa555-conjugated goat anti-
rabbit antibody (Invitrogen, USA), 1:200 dilution of Alexa
Fluor 488 conjugated Phalloidin (Invitrogen, USA) and
1 μM DAPI for 45 min at RT in dark. For co-
immunofluorescent staining of golgin-97, a marker for the
Golgi apparatus, and Cx26 proteins, cells were incubated
with primary antibodies (rabbit anti-Cx26 antibody
(1:500) and mouse anti-golgin-97 (1:1000) (Invitrogen,
USA)) for 1 h at room temperature. Then, secondary
antibodies (Alexa555-conjugated goat anti-rabbit (Invitro-
gen, USA) and Alexa488-conjugated goat anti-mouse
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DAPI were applied to cells for 45 min at RT in dark. After
washing with PBS, coverslips were dipped in distilled
water, dried and mounted on glass slides. Staining was
verified under fluorescence microscope (IX83, Olympus,
Japan) with x40 or x100 oil-immersion objective and im-
ages were taken with a CCD digital camera.
For co-labeling of Rhodamine labeled Wheat Germ Ag-
glutinin (WGA) and Cx26, after washing cells with PBS
twice, 1:200 dilution of Rhodamine labeled WGA (5 mg/
ml, Vector Labs, USA) was applied to cells for 30 min at
4 °C. Following the wash with PBS, cells were fixed and
immunostained with Cx26 as explained above. Staining
was verified under fluorescent microscope (IX83, Olym-
pus, Japan) with x100 oil objective and images were taken
with a CCD digital camera.
Dye uptake
N2A cells were transfected with pIRES2EGFP2 clones
for dye uptake assays with neurobiotin (NB, 287 Da, +1
charge, Vector Labs, USA). 24 h after transfection, cells
were washed with PBS and incubated with Ca+2 free
medium or medium with physiological calcium concen-
trations for 20 min at 37 °C. Cells were then incubated
with 0.5 mg/ml NB for 20 min at 37 °C [19]. Next, cells
were washed with PBS containing 3,2 mM CaCl2 three
times for 10 min and were fixed with 4 % PFA for
20 min at room temperature. Subsequently, fixed cells
were permeabilized with 0.1 % Triton-X 100 for 10 min,
blocked with 3 % BSA-0.1 % TritonX-100 for 15 min
and incubated with tetra-methyl rhodamine isothiocyan-
ate (TRIT-C) conjugated streptavidin (1:1000 dilution,
Pierce, USA) for 30 min at RT in dark. After washing
with PBS three times for 10 min, images were acquired
with a fluorescence microscope (IX71, Olympus, Japan)
using the same exposure times. For carbenoxolone
(CBX) treatment, cells were initially incubated with cal-
cium free medium containing 100 μM CBX for 20 min
and then NB in the same medium was applied to the
cells as explained above.
Image analysis for signal intensity determination was
performed with ImageJ (NIH, USA) program. During
image analysis, after subtracting the background in
merged images of red and green channels, the same pa-
rameters were applied to threshold the images for the
measurement of red signal intensities of fluorescence
only in GFP positive cells.
Measurement of Intracellular calcium levels
Flow cytometry was used for the measurement of in-
ternal calcium content with Fluo-3 AM Ca+2 indicator
(Invitrogen, USA) [18]. N2A cells (5x105) were plated
onto 6 well plates and transfected with pCS2+ clones.
Cells were washed with Ca+2 free PBS or physiologicalmedium twice for 5 min and incubated with 5 μM Fluo-
3 AM at 37 °C for 30 min. Then, cells were washed with
PBS, trypsinized and resuspended in divalent cation free
Hank’s Balanced Salt Solution (HBSS) [44] and analyzed
with FACSCANTO (BD Biosciences, USA).
Colocalization analysis
The determination of colocalization of Cx26 and the
Golgi apparatus marker, golgin-97, was carried on by
using Fiji Coloc 2 plug-in. Costes’ colocalization coeffi-
cient was calculated that compares a pair of images from
different fluorescent channels and quantifies the statis-
tical significance of colocalization [45].
Statistical analysis
All results were expressed as mean (± standard devi-
ation). For colocalization quantification, first the pixels
in the green and red channels were correlated to calcu-
late a Pearson’s coefficient (PC) and then pixels in green
channel were randomized and correlated with the original
red channel for 200 times. PCs from 200 perturbations
were compared with the original PC of non-randomized
image and if original PC is higher than 95 %, a significant
colocalization was accepted for the image. Groups were
compared using ANOVA followed by Tukey’s HSD for all
results. Colocalization data that only have positive or
negative results were compared using Kruskal-Wallis rank
sum test followed by Mann–Whitney test. Comparison of
samples in the absence and the presence of CBX was done
by using Student’s t-test. Statistical significance was con-
sidered for p < 0.05.
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